ECOVYST INC (NYSE:ECVT) Posts Mixed Q2 2025 Results with EPS Beat and Revenue Shortfall Ecovyst Inc. (
NYSE:ECVT ) reported mixed Q2 2025 results, beating EPS estimates by 20% but missing revenue targets. Shares dipped 1.07% pre-market amid cautious investor sentiment.
3 Small-Cap Gems Trading at 52-Week Lows With 2X Upside These three undervalued small-cap stocks could pack a mighty punch for investors looking for long-term, low cost holdings.
ECVT Stock Earnings: Ecovyst Misses EPS, Misses Revenue for Q1 2024 ECVT stock results show that Ecovyst missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
The 7 Best Tech Stocks To Buy Now: October 2023 Although the innovation sector got overheated, certain underappreciated ideas make up the best tech stocks to buy now.
Top 5 Materials Stocks You'll Regret Missing This Quarter The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
Celanese Stock Flexes Muscles; Climbs 40% In 4 Months Celanese stock shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday U.S. stocks traded higher, with the Nasdaq gaining more than 200 points on Tuesday. Here are some big stocks recording losses in today’s session.
Ecovyst: Q3 Earnings Insights Ecovyst (
NYSE:ECVT ) reported its Q3 earnings results on Tuesday, November 1, 2022 at 06:15 AM. Here's what investors need to know about the announcement. Earnings Ecovyst missed estimated earnings by 4.17%, reporting an EPS of $0.23 versus an estimate of $0.24.
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday Gainers ChemoCentryx, Inc. (
NASDAQ: CCXI ) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.
